Kinfo
CE

Bristol-Myers Squibb Company Ce

CELG.RINYSE·US · USD
$0.09
-0.01 (-5.34%)
Prices as of August 13, 2026 · market closed

Price

Key statistics

Valuation
Market cap0.00 USD
Enterprise value50.10B USD
Trailing P/E0.13
Forward P/E0.00
PEG ratio-0.00
Price / sales0.00
Price / book0.02
Profitability
Gross margin-2.50%
Operating margin0.00%
Profit margin10.24%
Return on assets7.61%
Return on equity24.56%
Income (TTM)
Revenue255.11B USD
Gross profit26.13B USD
EBITDA28.74B USD
Net income14.50B USD
Diluted EPS$0.71
Rev. growth (YoY)-9.64%
Balance sheet
Total cash0.00 USD
Total debt66.79B USD
Debt / equity1.15
Current ratio1.60
Book value / share$2.74
Cash flow (TTM)
Operating cash flow10.97B USD
Levered free cash flow14.50B USD
Shares & price
Shares outstanding20.41B
Float0.00
Held by institutions0.00%
Beta0.00
50-day MA$0.00
200-day MA$0.00
52-week high$0.28
52-week low$0.02
Dividends
Forward rate
$0.16
Yield
173.72%
Payout ratio
0.00%
Frequency
Annual
Recent payments
  • 2022-10-04$0.04
Earnings (EPS)
DateEst.ActualSurprise2026-01-296.456.57+1.86%2025-09-140.03-0.02−166.67%

Frequently asked questions about Bristol-Myers Squibb Company Ce